Director · Faeth Therapeutics, Inc. · Sensei Biotherapeutics, Inc.
Side
C
Value
—
Shares
44.8K
Price
—
Executed
Jun 15, 2026
Disclosed
Jun 16, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 15 executedJun 16, 2026 disclosed
FTH · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Derivative conversion — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hahn Stephen M. filed this Form 4 reporting a derivative conversion of FTH on Jun 15, 2026. It became public on Jun 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Hahn Stephen M.cik:0002137706
Issuer
Faeth Therapeutics, Inc.cik:0001829802
Revision history · 0
No field has changed since this record was first ingested.
